Cargando…
Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use
Saccharomyces cerevisiae has recently been used as an ingredient in probiotic supplements. Invasive Saccharomyces infection have been documented, and multiple predisposing risk factors have been identified including critical illness, ICU admission, antibiotics use, central venous catheters, probioti...
Autores principales: | Fadhel, Mustafa, Patel, Swapnil, Liu, Edward, Levitt, Michael, Asif, Arif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251791/ https://www.ncbi.nlm.nih.gov/pubmed/30505677 http://dx.doi.org/10.1016/j.mmcr.2018.11.003 |
Ejemplares similares
-
Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
por: Appel-da-Silva, Marcelo C., et al.
Publicado: (2017) -
SACCHAROMYCES CEREVISIAE FUNGEMIA IN A PEDIATRIC PATIENT AFTER TREATMENT WITH PROBIOTICS
por: Romanio, Mariá Ribas, et al.
Publicado: (2017) -
Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature
por: Atıcı, Serkan, et al.
Publicado: (2017) -
Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements
por: Rannikko, Juha, et al.
Publicado: (2021) -
Disseminated Pulmonary with Isolated Muscular Mucormycosis in an Acute Myeloid Leukemia Patient: A Case Report and Literature Review
por: Fadhel, Mustafa, et al.
Publicado: (2019)